Market Tracker

10/24 6:05pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

17.51
Data as of Oct 24
 +0.34 / +1.98%
Today’s Change
8.57
Today|||52-Week Range
20.29
+87.47%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close17.17
Today’s open17.22
Day’s range16.95 - 17.57
Volume585,608
Average volume (3 months)525,995
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-962.50%
Earnings growth (this year)-13.53%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-94.51%
P/E ratioNM
Price/Sales214.35
Price/Book9.60

Competitors

 Today’s
change
Today’s
% change
INSYInsys Therapeutics I...+0.61+1.59%
HZNPHorizon Pharma PLC-0.21-1.67%
PDLIPDL BioPharma Inc0.000.00%
CBPOChina Biologic Produ...+1.27+2.32%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$2.9M
Annual profit (last year)-$46.1M
Net profit margin-1,578.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin C. Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts